Login to Your Account

Ablynx Shares Fall as Pfizer Exits RA Alliance

By Cormac Sheridan
BioWorld Today Correspondent

Monday, November 7, 2011

Shares in Ablynx NV fell more than 18 percent Friday after Pfizer Inc. terminated an alliance on the development of nanobodies targeting tumor necrosis factor alpha (TNF-alpha).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription